Posts filtered by tags: Biotech[x]


 

For BioNTech, the COVID-19 vaccine was simply the opening act

BioNTech’s founding story dates back to the late 1990s, when CEO and co-founder Uğur Şahin, his wife and co-founder Özlem Türeci, and the rest of the seven-person founding team began their research. Focused specifically on an area dubbed “New Technologies,” mRNA stood out as one area with tremendous potential to deliver the team’s ultimate goal: Developing treatments personalized to an individual and their specific ailments, rather than the traditional approach of finding a solution that happens...
Tags: Health, Startups, TC, Tech, Biotech, Techcrunch Disrupt, Sahin, Mayfield, BioNtech, Ursheet Parikh, Ugur Sahin, Özlem Türeci, TechCrunch Disrupt 2021, EC Digital Biotech, TechCrunch Disrupt 2021 Health


Pfizer says its COVID-19 vaccine is safe and likely to work in younger children, and it's planning to ask for permission to use it in kids as young as 5

A group of kids elbow-bumping their tennis instructor after practice. Marko Geber/Getty Images Pfizer said its coronavirus vaccine is safe and likely to be effective in younger children. The pharmaceutical giant plans to soon apply for an expanded OK that includes 5- to 11-year-olds. The two-dose shot is already OK'd for people 12 years and older. See more stories on Insider's business page. The Pfizer-BioNTech coronavirus vaccine was safe and generated a promising immune response ...
Tags: Health, Science, News, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Pharmaceutical, Andrew Dunn, BioNtech, Albert Bourla, Coronavirus, COVID


The FDA's expert panel backs COVID-19 booster shots for adults 65 and older and those at highest risk of severe disease

The federal government has provided COVID-19 relief in numerous forms, from free vaccines to economic programs. Reuters An expert panel recommended that the FDA authorize booster shots for older and vulnerable adults. The doctors and health experts who advise the FDA say data suggests younger people are still well protected. The panel vote down a proposal to make boosters available to everyone 16 and older. See more stories on Insider's business page. An expert panel advising the Food...
Tags: Health, Science, News, Cdc, Kaiser Permanente, Israel, US, Trends, United States, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Committee


Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works

Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals done to date — Gingko is going public through a merger with Soaring Eagle Acquisition Corp., which was announced in May.  Shares opened at $11.15 each this morning under the ticker DNA — biotech ...
Tags: Startups, TC, Ipo, Dna, Tech, SEC, New York Stock Exchange, Biotech, CBG, Initial Public Offering, Ginkgo Bioworks, Exit, Nyse, Genentech, Kelly, SPAC


Ginkgo Bioworks, valued at $15B, begins trading today: Here’s how their business works

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Ginkgo’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals done to date — Ginkgo is going public through a merger with Soaring Eagle Acquisition Corp., which was announced in May.  Shares opened at $11.15 each this morning under the ticker DNA — biotech ...
Tags: Startups, TC, Ipo, Dna, Tech, SEC, New York Stock Exchange, Biotech, CBG, Initial Public Offering, Ginkgo Bioworks, Exit, Nyse, Genentech, Kelly, SPAC


The COVID-19 booster debate is a mess. Here's why we'll probably get extra shots anyway.

President Joe Biden gets a COVID-19 vaccine. Demetrius Freeman/The Washington Post via Getty Images The US debate over booster shots has devolved into a confusing and noisy mess. The next week should bring clarity, with FDA and CDC reviews wrapping up. Boosters are justified for older adults, experts told Insider, but there's less data on younger people. See more stories on Insider's business page. The debate over COVID-19 booster shots in the US has devolved into a noisy, confu...
Tags: Health, Science, News, Washington Post, Cdc, Brown University, US, Trends, Joe Biden, Analysis, Healthcare, Delta, Food And Drug Administration, World Health Organization, Fda, Pfizer


New Zealand startup HeartLab raises $2.45M to bring heart scanning software to the US

New Zealand-based medtech startup HeartLab has raised $2.45 million in seed funding that it says will help the company expand its AI-powered heart scanning and reporting platform to cardiologists in the United States by early next year. HeartLab provides an end-to-end solution for echocardiograms, the ultrasound tests that doctors use to examine a patient’s heart structure and function. Not only does the software help sort and analyze ultrasound images to help doctors diagnose cardiovascular dis...
Tags: Health, Startups, TC, US, San Francisco, Tech, Artificial Intelligence, United States, SaaS, New Zealand, Fda, Biotech, Founders Fund, Healthtech, Hewitt, Scott Nolan


A massive study from Israel suggests older adults were far less likely to develop severe COVID-19 after a booster shot, but the finding carries major limitations

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP A third dose of Pfizer's coronavirus vaccine dramatically reduces the risk of infection and severe illness for older adults, a new study found. A team of researchers in Israel published the findings Wednesday in The New England Journal of Medicine. Still, an expert urged caution on interpreting the findings, saying the study...
Tags: Health, Science, News, Israel, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, Murray, New England Journal of Medicine, Tel Aviv Israel


FDA releases documents outlining Pfizer's case for COVID-19 booster shots

Vials of the Pfizer-BioNTech Covid-19 vaccine. Patrick Fallon/AFP via Getty Images The FDA released documents Wednesday giving a look at Pfizer's case for COVID-19 booster shots. The data shows a third dose of Pfizer's shot raised antibody levels with no major safety concerns. An expert panel will make recommendations to the FDA on booster shots on Friday. See more stories on Insider's business page. The US Food and Drug Administration published documents on Wednesday that prov...
Tags: Health, UK, Science, News, Cdc, Trends, Healthcare, Delta, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, US Food and Drug Administration, Pharmaceutical, Andrew Dunn


See the biotech and pharma companies that are growing the fastest and pay workers the most

A scientist lowers biological samples into a liquid nitrogen storage tank. Dan Kitwood/Getty Images/Cancer Research UK Insider compiled data on the fastest-growing biotech and pharma companies. We examined how much they're paying employees and executives. One company paid its median employee $701,000, while dozens of CEOs earned more than $18 million. See more stories on Insider's business page. As the drug industry has grown, companies are competing to hire and retain the best p...
Tags: Trends, Pay, Compensation, Healthcare, Biotech, Pharma, Hiring, Novavax, Company Growth, Moderna, Dan Kitwood, Stanley Erck, Getty Image, Precigen, COVID, Dispensed


Teatis, low-sugar superfood powders developer for diabetics, closes seed round

A serial entrepreneur Hiroshi Takatoh recognized the need for convenient and nutritious food for critically ill consumers after losing his late wife to cancer. Takatoh founded Teatis, a plant-based sugar blocking superfood powder for diabetic consumers, in 2017 in stealth mode and went fully operational in April 2021 by teaming up with a group of doctors and registered nutritionists. Teatis announced today it has raised $700,000 seed funding to advance its growth in the US market.  The seed mone...
Tags: Health, Food, TC, Asia, Japan, Funding, US, Tech, Diabetes, Biotech, Telehealth, Mercari, Foodtech, Europe Plant, Plant-based Food, Genesia Ventures


Meet biotech's top young leaders

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We highlighted the 9 biotech leaders under 40 transforming healthcare;Why getting down to zero COVID-19 cases in the US isn't likely;What it was like inside a Texas abortion clinic that stayed open till midnight on the eve of the new abortion ban. If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... ...
Tags: Texas, Politico, US, Trends, Healthcare, Biotech, Fort Worth, Fort Worth Texas, Newsletters, Vivek Murthy, Murthy, Lydia Ramsey Pflanzer, Dispensed, Lydia Read, 30 Under 40, Insider Healthcare


Jeff Bezos has invested in an anti-aging biotech startup, a report says

Jeff Bezos laughs as he speaks about his flight on Blue Origin’s New Shepard into space during a press conference on July 20, 2021 in Van Horn, Texas. Joe Raedle/Getty Images An anti-aging research company called Altos Labs was founded earlier this year. Sources told MIT Tech Review the company claims Jeff Bezos as one of its investors. Altos Labs hopes to develop technology to reprogram human cells, sources told MIT Tech Review. See more stories on Insider's business page. A new compa...
Tags: Amazon, Japan, UK, News, California, Trends, Palo Alto, Jeff Bezos, Biotech, Delaware, Yuri Milner, Bay Area, Anti-aging, Companies House, Bezos, MIT Tech Review


Jeff Bezos has reportedly invested in an anti-aging biotech startup

Jeff Bezos laughs as he speaks about his flight on Blue Origin’s New Shepard into space during a press conference on July 20, 2021 in Van Horn, Texas. Joe Raedle/Getty Images An anti-aging research company called Altos Labs was founded earlier this year. Sources told MIT Tech Review the company claims Jeff Bezos as one of its investors. Altos Labs hopes to develop technology to reprogram human cells, sources told MIT Tech Review. See more stories on Insider's business page. A new compa...
Tags: Amazon, Japan, UK, News, California, Trends, Palo Alto, Jeff Bezos, Biotech, Delaware, Yuri Milner, Bay Area, Anti-aging, Companies House, Bezos, MIT Tech Review


The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data

President Joe Biden speaks about prescription drug prices and his "Build Back Better" agenda from the East Room of the White House, Thursday, Aug. 12, 2021, in Washington. Associated Press/Evan Vucci The heads of the FDA and CDC are pushing back on the White House's plan for COVID-19 booster shots. The top health officials say they need more time to review data on extra doses, . It's the latest setback to the Biden administration's booster plan, which has also prompted resigna...
Tags: Health, Science, News, Cdc, White House, US, Trends, Joe Biden, Healthcare, The Times, Fda, Pfizer, Biotech, Biden, Times, Johnson Johnson


What's ahead for COVID-19 drugs and vaccines in 2021

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:The 10 big events to pay attention to when it comes to COVID-19 vaccines and treatments;We broke down where the top biotechs (according to VCs) are based;Find out why One Medical made its $1.4 billion bet on Iora. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...As you might expect, there'll be ...
Tags: Boston, Medical, Los Angeles, Trends, Mit, Healthcare, Medicare, Pfizer, Biotech, Vaccines, Elizabeth Holmes, Bay Area, Andrew, Newsletters, Treatments, Andrew Dunn


Meet the 9 Bay Area biotechs VCs say are poised to take off

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:Meet the 9 Bay Area biotechs VCs say are poised to take off';Inside the psychedelics company that biotech investors are betting big on;What to know about past COVID-19 infections and your immunity. If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Shutterstock 9 top Bay Area biotechs that...
Tags: UK, US, San Francisco, Trends, Healthcare, Biotech, Bay Area, Psychedelics, Los Angeles International Airport, Newsletters, Mario Tama Getty, Tom Bradley International Terminal, COVID, Lydia Ramsey Pflanzer, Dispensed, Insider Healthcare


We got our best picture yet of Dollar General's healthcare plans

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We got a better picture of Dollar General's healthcare ambitions;These are the states with the most biotech companies;Why you aren't allowed to know which variant gave you COVID-19.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Jeremy Hogan/SOPA Images/LightRocket via Getty Images ...
Tags: Florida, Texas, California, Massachusetts, US, Trends, Paris, Healthcare, Delta, Biotech, Kaiser Health News, Elizabeth Holmes, Newsletters, Dollar General, Vasos, Todd Vasos


Why experts think life will get better by 2023 - if enough people get vaccinated

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and I'm catching up after taking some time off to hike the Grand Canyon from rim to rim.This week in healthcare news:The FDA approved Pfizer's coronavirus vaccine - but the pandemic endgame isn't here yet;We've got interactive maps and quizzes that break down the biotech industry;Why experts think it'll take more than technology to diversify clinical trials. If you're new to this newsletter, sign up here....
Tags: US, Trends, Mit, Getty Images, Healthcare, Miami, Fda, Pfizer, Biotech, Vaccines, Nih, Grand Canyon, Mckinsey, Andrew, Big Pharma, Malik


Avalo uses machine learning to accelerate the adaptation of crops to climate change

Climate change is affecting farming all over the world, and solutions are seldom simple. But if you could plant crops that resisted the heat, cold, or drought instead of moving a thousand miles away, wouldn’t you? Avalo helps plants like these become a reality using AI-powered genome analysis that can reduce the time and money it takes to breed hardier plants for this hot century. Founded by two friends who thought they’d take a shot at a startup before committing to a life of academia, Avalo ha...
Tags: Fundings & Exits, Startups, TC, Y Combinator, Science, Funding, Tech, Artificial Intelligence, Monsanto, Biotech, Collins, Brendan, CSO, Alvarez, Mendel, Mariano Alvarez


The pandemic created a bunch of biotech billionaires. Take our 5-question quiz to see how well you know the pay trends shaping the drug industry.

From left: Stephane Bancel of Moderna, Leonard Schleifer of Regeneron, and Stanley Erck of Novavax. Steven Ferdman/Getty Images; Adam Jeffery/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images; Novavax; Skye Gould/Insider Several biotech executives became billionaires last year, as the pandemic drove vaccine sales and stock market fervor. How did that wealth trickle down through the industry? See if you can guess what executives and employees earned. This quiz is part of Insider's deep...
Tags: Science, News, Trends, Getty Images, Compensation, Healthcare, Pay Gap, Biotech, Sawyer, Pharmaceutical, Novavax, Regeneron, Skye Gould, Stanley Erck, Stéphane Bancel, Salary Data


FDA fully approves Pfizer-BioNTech’s COVID-19 vaccine

The U.S. Food and Drug Administration (FDA) has granted full approval to Pfizer-BioNTech’s COVID-19 vaccine, making it the first vaccine to achieve that status. The mRNA-based vaccine has been available since late last year through an Emergency Use Authorization (EUA), and will continue to be offered under that designation for those aged 12 to 15 until that separate approval process goes through, but the U.S. drug regulator now recognizes the Pfizer vaccine as fully approved and certified for ad...
Tags: Health, TC, Tech, Fda, Pfizer, Vaccine, Biotech, U S Food and Drug Administration FDA, EUA, Mayfield, Moderna, BioNtech, Ursheet Parikh, COVID-19, Emergency Use Authorization EUA, Ugur Sahin


GSK and R/GA Ventures are launching a health studio for startups

GSK Next, the innovation arm of GlaxoSmithKlein, is launching a new mentorship and business development program. Called the Re/Wire Health Studio, the program will eventually select six startups who will win access to nine weeks of mentoring, business development expertise, and cash grants.  The Re/Wire Health Studio is designed for growth and early-stage startups focused on “everyday health.” That means products that aid in detecting long-term health problems, incentivize proactive care, o...
Tags: Health, TC, Science, US, Tech, Biotech, GSK, Tate, GSK Consumer Healthcare, R GA Ventures, Nick Tate, Re Wire Health Studio, Re Wire Health, Global Digital Innovation


VCs warn of a glut of cancer startups

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:Biotech VCs are worried there are too many cancer-treatment startups getting funded right now;Why experts think Iceland is proof coronavirus vaccines work;We read through Devoted Health's first-half of 2021 financial filings so you don't have to.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...F...
Tags: Shutterstock, Washington Post, US, America, Trends, Bloomberg, Healthcare, Iceland, Biotech, Vaccines, Biden, KEYTRUDA, Newsletters, Kevin Burns, Cancer Treatments, RTW Investments


Delta's surging and antibodies are waning: What to know about when we'll need COVID-19 booster shots

Moderna has soared over the past year on the back of its coronavirus vaccine. Radek Mica/Getty Images Should the US start offering people an extra COVID-19 vaccines dose? Supporters cite signs of waning protection and data suggesting a booster shot would help. Others say boosting now is unnecessary, because the shots still prevent hospitalizations and death. See more stories on Insider's business page. The debate over whether the US should roll out extra doses of coronavirus vaccines...
Tags: Health, Science, Cdc, France, Germany, Israel, Nbc News, US, Trends, Analysis, Healthcare, Delta, World Health Organization, Philadelphia, Fda, Pfizer


The FDA signed off on COVID-19 booster shots for immunocompromised people

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:The FDA signs off on COVID-19 booster shots for immunocompromised people;Meet the new potential dealmakers of the drug industry;Three ways Dollar General could get into healthcare. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Registered Nurse Robert Orallo administers the Pfizer Covid-19 va...
Tags: US, Trends, Healthcare, Fda, Biotech, Vaccines, Bayer, Andrew, Anchorage, Bayer AG, Big Pharma, US Israel, Newsletters, Frederic J Brown, Dollar General, Noubar Afeyan


Meet biotech's new potential acquirers

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We rounded up the biotechs most likely to usurp Big Pharma as major acquirers;Flagship Pioneering's Noubar Afeyan walked us through the 4 steps he uses to create biotech companies;Indoor dining is out for health experts, who shared what they're doing to stay safe as Delta spikes.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydia...
Tags: Russia, US, Trends, Healthcare, Delta, M&a, Biotech, Bayer AG, Big Pharma, Newsletters, Noubar Afeyan, Werner Baumann, Moderna, Flagship Pioneering, Getty Images Health, Mikhail Japaridze


Vaccine developer GreenLight is going public in a $1.5 billion SPAC deal

Jason Redmond/AFP/Getty Images Vaccine developer GreenLight Biosciences is going public through a $1.5 billion SPAC deal, according to a Wall Street Journal report. The company is developing its own COVID-19 vaccine for clinical trials in Africa next year. The SPAC deal comes as interest in such blank-check arrangements has diminished in recent months. Sign up here for our daily newsletter, 10 Things Before the Opening Bell. Vaccine developer GreenLight Biosciences is going public through...
Tags: Africa, Trends, Markets, BNP Paribas, Biotech, Vaccines, Pharma, Wall Street Journal, SPAC, Jason Redmond, Jeremy Grantham, RNA, Moderna, Greenlight Biosciences, COVID, MI Exclusive


Vaccines are seatbelts, not armor

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We got a reminder that "vaccines, they're not magic";The 24 biotech startups top VCs say are poised to take off;Check out the presentation Yelp for holistic-care startup Kensho used to raise its seed round. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Marianne Ayala/Insider Rethink...
Tags: US, Newsletter, Trends, Healthcare, Delta, Vaccine, Andreessen Horowitz, Biotech, HIPAA, Moderna, Andrew Dunn, RTW Investments, Avery Hartmans, Hilary Brueck, Aria Bendix, Yeji Jesse Lee


24 biotech startups that are poised to take off

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:The 24 biotech startups VCs say will take off in the next year;Flawed ideas about testosterone are fueling Republican bills to ban trans kids in sports;Your COVID-19 vaccine isn't perfect.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... From left: Venture capitalists Abbie Celniker, Vineeta Ag...
Tags: Florida, Trends, Healthcare, Delta, Andreessen Horowitz, Biotech, Vaccines, Newsletters, Dan Mullan Getty, Laurel Hubbard, RTW Investments, Ian MacNicol Getty, Trans Athletes, Lydia Ramsey Pflanzer, BI Graphics, Dispensed